URIST MARSHALL (EVP & Co-Head Research & Inv.) sold 50.0% of their position (4.13K shares) of ROYALTY PHARMA PLC on the open market
Open‑market sale worth $238.8K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/30/2026ACC: 0001838139-26-000026
Officer· EVP & Co-Head Research & Inv.
Since Dec 2020
-4.13K
Net shares
Net seller
$238.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
4.13K disposed
Non-Derivative Transactions1
Class A Ordinary Shares
Direct
Shares
−4.13K
Price / share
$57.88
Trade value
$238.81K
% of position
50.0%
9/28/2026
8.25K→4.13K
Total
Net shares
−4.13K
Net value
-$238.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Ordinary Shares Direct | 9/28/2026 | S · Sale | −4.13K | $57.88 | $238.81K | 50.0% | 8.25K | 4.13K |
| Total | −4.13K | -$238.81K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A Ordinary Shares
IndirectShares owned19.02K
Total
19.02K indirect19.02K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A Ordinary Shares | 19.02K | Indirect |
| Total | 19.02K | 19.02K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported